Cargando…
Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia
INTRODUCTION: Strong epidemiologic evidence supports correlation between lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) and erectile dysfunction (ED). The link has biologic plausibility given phosphodiesterase type 5 (PDE5) expression in pelvic structures. PDE5 inhibitor...
Autores principales: | Govorov, Alexander, Kasyan, George, Priymak, Diana, Pushkar, Dmitry, Sorsaburu, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132596/ https://www.ncbi.nlm.nih.gov/pubmed/25140232 http://dx.doi.org/10.5173/ceju.2014.02.art10 |
Ejemplares similares
-
Current drug therapy of patients with BPH-LUTS with the special emphasis on PDE5 inhibitors
por: Kolontarev, Konstantin, et al.
Publicado: (2016) -
The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
por: Lee, Sung Won, et al.
Publicado: (2014) -
Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013) -
Bulking agents for urinary incontinence: what, when and where?
por: Kasyan, George, et al.
Publicado: (2015) -
Extended robotic salvage lymphadenectomy in patients with ‘node-only’ prostate cancer recurrence: initial experience
por: Kolontarev, Konstantin, et al.
Publicado: (2018)